How many employees does AC Immune have this year?
AC Immune has 115 undefined employees this year.
AC Immune Employees 2024
AC Immune Employees
115
Ticker
ACIU
ISIN
CH0329023102
WKN
A2AR5F
In 2024, AC Immune employed 115 people, a 0% change from the 115 number of employees in the previous year.
AC Immune Aktienanalyse
What does AC Immune do?
AC Immune SA is a biopharmaceutical company specializing in the discovery and development of drugs for the treatment of neurodegenerative diseases as well as cancer. It was founded in 2003 by a group of leading researchers in the field of neurodegeneration and is based in Lausanne, Switzerland. The company has established itself as one of the leading companies in Alzheimer's research in recent years. AC Immune SA focuses on developing drugs targeting protein aggregation that occurs in Alzheimer's and other neurodegenerative diseases in the brain. It has developed an innovative platform technology that allows for the development of specific antibodies that selectively bind to certain toxic or disease-causing proteins. AC Immune has developed a variety of proprietary technologies and platforms that enable rapid and efficient identification, testing, and optimization of therapeutics. Its main products are antibodies that therapeutically target Alzheimer's, Parkinson's, TAU, and Alpha-Synuclein prions. These antibodies that target protein disease-related plaques help slow disease progression and alleviate symptoms. AC Immune has also developed and tested drugs for cancer treatment. The company operates in two main segments: research and development, as well as clinical studies. It has a strong pipeline of products in development that are in various stages of clinical trials. These products target various diseases including Alzheimer's, Parkinson's, advanced stage cancer, prion diseases, neurodegenerative sanatoria, and Down syndrome. AC Immune SA collaborates closely with various academic research institutions, biotechnology companies, pharmaceutical companies, and government agencies to bring innovative therapies to market. It has formed numerous partnerships and alliances with renowned partners in the pharmaceutical, biotech, and life science industries to accelerate the translation of promising therapeutic approaches into clinical applications. Recently, AC Immune SA announced a partnership with Genentech, a leading company in the development of biological therapies and diagnostic procedures. The two companies are working together to develop treatments for Alzheimer's and several other neurodegenerative diseases. Another example is the collaboration with Eli Lilly and Company for the use of ACI-3024 in the fight against tauopathies, including Alzheimer's disease and progressive supranuclear palsy. AC Immune SA has a strong foundation in scientific research and development, as well as in the commercialization of therapeutics. The company has a comprehensive product pipeline aimed at developing innovative therapy options for patients with neurodegenerative diseases and cancer. With its proprietary technology platform and partnerships with leading companies in the biotech and pharmaceutical industries, AC Immune SA has great potential to make significant advances in the development of therapies that improve patients' lives and enhance their quality of life. AC Immune ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining AC Immune's Employee Base
AC Immune's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding AC Immune's operational capacity and future potential.
Year-to-Year Comparison
Assessing AC Immune's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
AC Immune's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in AC Immune’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about AC Immune stock
How many employees did AC Immune have compared to the previous year?
Compared to the previous year, AC Immune had 0% more employees.
What impact did the number of employees have on the company AC Immune?
The number of employees has a direct impact on the efficiency and productivity of AC Immune. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of AC Immune?
The number of employees can also have an impact on investors of AC Immune, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of AC Immune affect the company?
An increase in equity of AC Immune can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in AC Immune's equity affect the company?
A reduction in equity of AC Immune can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of AC Immune?
Some factors that can influence the equity of AC Immune include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of AC Immune so important for investors?
The equity of AC Immune is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at AC Immune influence the company?
The number of employees at AC Immune can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at AC Immune evolved in recent years?
In recent years, the number of employees at AC Immune has changed by 0.
How many employees does AC Immune currently have?
AC Immune currently has 115 undefined employees.
Why is the number of employees important for investors of AC Immune?
The number of employees is important for investors of AC Immune as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can AC Immune take to change the number of employees?
To change the number of employees, AC Immune can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does AC Immune pay?
Over the past 12 months, AC Immune paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AC Immune is expected to pay a dividend of 0 CHF.
What is the dividend yield of AC Immune?
The current dividend yield of AC Immune is .
When does AC Immune pay dividends?
AC Immune pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of AC Immune?
AC Immune paid dividends every year for the past 0 years.
What is the dividend of AC Immune?
For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.
In which sector is AC Immune located?
AC Immune is assigned to the 'Health' sector.
Wann musste ich die Aktien von AC Immune kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AC Immune from 12/4/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.
When did AC Immune pay the last dividend?
The last dividend was paid out on 12/4/2024.
What was the dividend of AC Immune in the year 2023?
In the year 2023, AC Immune distributed 0 CHF as dividends.
In which currency does AC Immune pay out the dividend?
The dividends of AC Immune are distributed in CHF.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von AC Immune
Our stock analysis for AC Immune Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AC Immune Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
